The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care

The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care

3.3 9
by Eric Topol
     
 

View All Available Formats & Editions


Now with a new postscript covering the unfolding health care revolution

Mobile technology has transformed our lives, and personal genomics is revolutionizing biology. But despite the availability of technologies that can provide wireless, personalized health care at lower cost, the medical community has resisted change. In The Creative Destruction of

…  See more details below

Overview


Now with a new postscript covering the unfolding health care revolution

Mobile technology has transformed our lives, and personal genomics is revolutionizing biology. But despite the availability of technologies that can provide wireless, personalized health care at lower cost, the medical community has resisted change. In The Creative Destruction of Medicine, Eric Topol—one of the nation’s top physicians—calls for consumer activism to demand innovation and the democratization of medical care. The Creative Destruction of Medicine is the definitive account of the coming disruption of medicine, written by the field’s leading voice.

Editorial Reviews

From the Publisher
"Topol weaves useful knowledge about how to evaluate the choices open to patients into this exciting account of the revolutionary changes we can expect." —Kirkus
Kirkus Reviews
The director of the Scripps Translational Science Institute suggests that in the not-too-distant future DNA testing and sequencing may become available on a smartphone. The former chairman of cardiovascular medicine at the Cleveland Clinic and founder of its cardiovascular gene bank, Topol looks to a future in which genomics will be one of the major tools of innovative, individualized medicine. "What constitutes evidence-based medicine today is what is good for a large population," he writes, "not for any particular individual." Not so in the future. The author is aware of instances in which pharmaceutical companies attempt to violate the principle of evidence-based medicine by suppressing negative results. In fact, Topol was the first to reveal "significant heart attack and stroke concerns for both Vioxx and Celebrex," information he published in the New England Journal of Medicine. As a result of his whistle-blowing, he was forced out of his position at the Clinic in 2004, when the two drugs were finally removed from the market. The author explains how "the large-scale randomized, double-blind, placebo-controlled clinical trial performed under the most rigorous conditions" will be superseded by individualized medicine. Sequencing the human genome opened up major new areas of preventative medicine; in the future these procedures will be able to identify medications that will benefit, or be injurious to, a small portion of the population who carry a specific genetic mutation, rather than the population at large. Topol weaves useful knowledge about how to evaluate the choices open to patients into this exciting account of the revolutionary changes we can expect.

Product Details

ISBN-13:
9780465061839
Publisher:
Basic Books
Publication date:
08/13/2013
Edition description:
First Trade Paper Edition, Revised and Expanded
Pages:
336
Sales rank:
263,748
Product dimensions:
6.10(w) x 9.10(h) x 1.00(d)
Age Range:
18 Years

What People are saying about this

From the Publisher
"Topol weaves useful knowledge about how to evaluate the choices open to patients into this exciting account of the revolutionary changes we can expect." —-Kirkus

Meet the Author


Eric J. Topol, M.D., is the director of the Scripps Translational Science Institute and co-founder and vice-chairman of the West Wireless Health Institute in La Jolla, California. He is a practicing cardiologist at the Scripps Clinic and a professor of genomics at The Scripps Research Institute. One of the top 10 most cited researchers in medicine, Topol was elected to the Institute of Medicine of the National Academy of Sciences and has led many of the trials that have shaped contemporary treatment for heart disease.

Customer Reviews

Average Review:

Write a Review

and post it to your social network

     

Most Helpful Customer Reviews

See all customer reviews >